The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Venlafaxine Hydrochloride
Venlafaxine Hydrochloride · VENLAFAXINE HYDROCHLORIDE 150 mg/1 · Tablet, Extended Release · Oral · Nivagen Pharmaceuticals, Inc.
NDC 75834-0218-00 · 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for venlafaxine hydrochloride (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA211323
- TE code
- AB
- Approval date
- Aug 29, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Venlafaxine Hydrochloride (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Advanced Rx of Tennessee, LLC | VENLAFAXINE HYDROCHLORIDE 37.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | VENLAFAXINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | VENLAFAXINE HYDROCHLORIDE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nivagen Pharmaceuticals, Inc. | VENLAFAXINE HYDROCHLORIDE 225 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | VENLAFAXINE HYDROCHLORIDE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | VENLAFAXINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | VENLAFAXINE HYDROCHLORIDE 225 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | VENLAFAXINE HYDROCHLORIDE 37.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Trigen Laboratories, LLC | VENLAFAXINE HYDROCHLORIDE 37.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Trigen Laboratories, LLC | VENLAFAXINE HYDROCHLORIDE 225 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | VENLAFAXINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | VENLAFAXINE HYDROCHLORIDE 225 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Venlafaxine Hydrochloride — NDC 75834-0218-00," retrieved September 3, 2026, https://drugdashboards.com/drug/75834021800.
Free to cite with attribution — see how the data is put together.